Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study).
Vignion-Dewalle AS, Abi Rached H, Thecua E, Lecomte F, Deleporte P, Béhal H, Hommel T, Duhamel A, Szeimies RM, Mortier L, Mordon S. Vignion-Dewalle AS, et al. Among authors: szeimies rm. JMIR Res Protoc. 2019 Apr 26;8(4):e12990. doi: 10.2196/12990. JMIR Res Protoc. 2019. PMID: 31025953 Free PMC article.
The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
Mordon S, Vignion-Dewalle AS, Abi-Rached H, Thecua E, Lecomte F, Vicentini C, Deleporte P, Béhal H, Kerob D, Hommel T, Duhamel A, Szeimies RM, Mortier L. Mordon S, et al. Among authors: szeimies rm. Br J Dermatol. 2020 Jan;182(1):76-84. doi: 10.1111/bjd.18048. Epub 2019 Aug 1. Br J Dermatol. 2020. PMID: 31021404 Clinical Trial.
Phototoxic reactions in healthy volunteers following photodynamic therapy with methylaminolevulinate cream or with cream containing 5-aminolevulinic acid: a phase II, randomized study.
Steinbauer J, Schreml S, Karrer S, Ackermann G, Babilas P, Landthaler M, Szeimies RM. Steinbauer J, et al. Among authors: szeimies rm. Photodermatol Photoimmunol Photomed. 2009 Oct;25(5):270-5. doi: 10.1111/j.1600-0781.2009.00455.x. Photodermatol Photoimmunol Photomed. 2009. PMID: 19747247 Clinical Trial.
Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus.
Morton CA, Wulf HC, Szeimies RM, Gilaberte Y, Basset-Seguin N, Sotiriou E, Piaserico S, Hunger RE, Baharlou S, Sidoroff A, Braathen LR. Morton CA, et al. Among authors: szeimies rm. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1718-23. doi: 10.1111/jdv.12974. Epub 2015 Jan 28. J Eur Acad Dermatol Venereol. 2015. PMID: 25627399 Review.
Use of Lesion Response Rate in Actinic Keratosis Trials.
Szeimies RM, Atanasov P, Bissonnette R. Szeimies RM, et al. Dermatol Ther (Heidelb). 2016 Dec;6(4):461-464. doi: 10.1007/s13555-016-0145-2. Epub 2016 Sep 19. Dermatol Ther (Heidelb). 2016. PMID: 27645828 Free PMC article.
271 results